Search

Zai Lab Ltd ADR

Suletud

SektorTervishoid

26.03 -2.55

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

25.82

Max

26.63

Põhinäitajad

By Trading Economics

Sissetulek

191K

-51M

Müük

6.7M

106M

Aktsiakasum

-0.46

Kasumimarginaal

-47.808

Töötajad

1,784

EBITDA

-2.1M

-46M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+22.19% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. nov 2026

Turustatistika

By TradingEconomics

Turukapital

826M

2.9B

Eelmine avamishind

28.58

Eelmine sulgemishind

26.03

Uudiste sentiment

By Acuity

50%

50%

171 / 340 Pingereas Healthcare

Zai Lab Ltd ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. aug 2026, 23:56 UTC

Correlated Moves
News

The Vanguard Mortgage-Backed Securities ETF remains roughly flat in after-market trading amid rising yields and concerns over high borrowing costs and geopolitical risks.

20. aug 2026, 23:51 UTC

News

Re/Max Holdings Inc shares rise in after-market hours following stockholder election results for the merger with Real Brokerage Inc, with cash-electing shares set to receive $4.33.

20. aug 2026, 23:51 UTC

News

Starbucks is laying off over 200 corporate workers as part of its turnaround strategy. Shares are modestly higher in after-market trading.

20. aug 2026, 23:46 UTC

News

Uber Technologies Inc shares are trading higher in after-market hours, closing near $78.56, with mixed sentiment in the options market.

20. aug 2026, 23:41 UTC

News

Johnson & Johnson shares are higher in after-market trading following operational sales growth and a raised full-year outlook amid recent FDA clearances for its bronchoscopy software.

20. aug 2026, 23:31 UTC

Correlated Moves
News

Coinbase shares are higher in after-market trading as CEO Brian Armstrong highlights optimism for the CLARITY Act and Bitcoin's recent rebound.

20. aug 2026, 23:31 UTC

Correlated Moves
News

Ethereum gains today, supported by strong ETF inflows and rising holder numbers. Bitcoin's surge past $69K also contributes to positive sentiment.

20. aug 2026, 23:31 UTC

Correlated Moves
News

Ethereum gains today amid strong ETF inflows and rising holder numbers. Bitcoin's increase above $69K also boosts sentiment in the cryptocurrency market.

20. aug 2026, 23:26 UTC

Event
News

Veeva Systems appoints Dan Rizzo as Executive Vice President of Sales, Consulting, and Services, effective October 2, 2026. Shares are near unchanged in after-hours trading.

20. aug 2026, 23:26 UTC

News

Provident Financial Services priced a $175 million offering of subordinated notes due 2036. Shares traded lower in after-market hours following the announcement.

20. aug 2026, 23:26 UTC

News

FedEx Corp secured a $2.72 billion contract extension from the U.S. Transportation Command, with shares trading higher in after-market hours.

20. aug 2026, 23:26 UTC

News

Skyworks Solutions shares are lower in after-market hours following BMO Capital's Market Perform rating, suggesting limited upside potential from current levels.

20. aug 2026, 23:26 UTC

News

Warner Bros Discovery shares rise in after-hours trading amid scrutiny over its proposed acquisition by Paramount Skydance and delayed merger timeline.

20. aug 2026, 23:21 UTC

News

Alnylam Pharmaceuticals Inc. shares are higher in after-market trading, recovering from earlier lows despite lowered full-year sales guidance for its TTR products.

20. aug 2026, 23:21 UTC

News
Social Media
Event

OSI Systems reported record annual revenues of $1.79 billion, but results missed expectations due to delivery delays, leading shares to trade lower after hours.

20. aug 2026, 23:21 UTC

News

Walt Disney Co's stock rose in after-market trading following plans for an Employee Stock Purchase Plan and Morgan Stanley's positive outlook on valuation.

20. aug 2026, 23:11 UTC

News

Hawaiian Electric Industries has restored power to all customers in Oahu and Maui after Hurricane Lala, with shares trading higher in after-market hours.

20. aug 2026, 23:06 UTC

News

Eaton Corporation shares are trading higher in after-market hours following coverage initiation by BMO and Baird analysts, who both assigned an Outperform rating.

20. aug 2026, 23:06 UTC

News

After-market shares of Interactive Brokers Group Inc are higher as client margin loan balances rose to $100.7 billion in July, a 49% year-over-year increase.

20. aug 2026, 23:06 UTC

Correlated Moves
ETF Constituents
News

Vanguard Small-Cap ETF trades roughly flat since Thursday's close.

20. aug 2026, 23:06 UTC

News
Correlated Moves

Royal Caribbean Cruises has completed a $1.25 billion public offering of senior unsecured notes, with shares trading higher in after-market hours.

20. aug 2026, 23:06 UTC

News

Nextera Energy has secured funding agreements for up to 10 gigawatts of gas generation, supporting cash flow expectations as shares trade higher after market hours.

20. aug 2026, 23:06 UTC

Correlated Moves
News

Doubts about Treasury Secretary Bessent's bond-buyback plans pressure the bond market. The iShares 20+ Year Treasury Bond ETF is little changed in after-market hours.

20. aug 2026, 23:06 UTC

News

Iovance Biotherapeutics reached a 52-week high after UBS raised its target price to $7, noting strong second-quarter sales of $91 million.

20. aug 2026, 23:01 UTC

News
Social Media

Boston Beer Company shares decline in after-market hours following CFO transition announcement. Broader market pressure stems from losses in major companies like Walmart Inc.

20. aug 2026, 23:01 UTC

News
Social Media
Event

Ross Stores reported second-quarter net income of $851.3 million and raised fiscal year 2026 EPS guidance, driving shares higher in after-market trading.

20. aug 2026, 23:01 UTC

News

Fiserv Inc. is higher in after-market trading following its selection by Flagstar Bank for a modernization project and a partnership with Thunes.

20. aug 2026, 23:01 UTC

Event
News

Flowers Foods Inc shares declined in after-market hours following disappointing second-quarter results and a lowered full-year sales guidance. Net income dropped 30.3% to $40.7 million.

20. aug 2026, 23:01 UTC

News

Photronics Inc. shares are lower in after-market trading, reflecting broader market declines amid significant losses from major companies like Walmart Inc.

20. aug 2026, 23:01 UTC

News

Boeing Co secured $173.8 million in contracts from the U.S. Department of Defense, contributing to shares trading higher in after-market hours.

Võrdlus sarnastega

Hinnamuutus

Zai Lab Ltd ADR Prognoos

Hinnasiht

By TipRanks

22.19% tõus

12 kuu keskmine prognoos

Keskmine 32.65 USD  22.19%

Kõrge 45 USD

Madal 21.6 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Zai Lab Ltd ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

3

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

171 / 340 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat